科学 · 乔治·怀特塞兹
乔治·怀特塞兹逝世,享年87岁,为化学留下务实挑战
这位哈佛化学家帮助实现了分子尺度上的表面工程化,并为实验室稀缺的地方探索更简便的医学检测。
文字 阅读需 5 分钟 · 23 个来源
原语言视频
译自英文原文。
读者投票
研究资助方应如何平衡基础化学与实用诊断工具?
让表面成为可工程化的对象
怀特塞兹的一项重要成就涉及一种仅有一层分子厚度的涂层。这类涂层称为自组装单分子层,让研究人员能够通过材料表面的分子覆盖层来控制其表面性质。其意义不在于单纯追求微小,而在于能够设计表面的行为。11
微流控的潜在优势相当可观:减少样本材料和试剂用量、操控生物细胞、缩小实验室仪器体积,以及提高实验自动化程度。较小的设备也可能有助于降低成本。不过,这些是这项技术能够支持的能力,并非每一种采用该技术制造的设备都能自动宣称具备的、经过测量的实际效益。7
从原型到医疗服务的距离
一个结合纸张与手机的项目,让怀特塞兹的务实追求变得尤为具体。他与安德烈斯·W. 马丁内斯、斯科特·T. 菲利普斯、伊曼纽尔·卡里略、塞缪尔·W. 托马斯三世和海亚特·辛迪合作,帮助开发了一种原型系统,将纸基微流控设备与拍照手机结合起来。该系统可量化生物检测结果,并通过数字方式传送结果,以供异地分析。6
这一成果展示了将简易检测设备与远程分析相连的一种方法。但根据现有证据,它并未证明这种方法已在临床常规使用,也未确定每次检测的具体价格或经验证的诊断准确性。这一区别并非无关紧要的技术细节。原型表明某种方法在测试条件下可行;要实现可靠的医疗服务,还需要做得多得多。
怀特塞兹所在团队清楚地指出了问题。面向低资源环境的诊断工具必须经得起严酷的运输和储存条件。使用者可能缺乏培训,有时还会承受相当大的压力。维护和支持基础设施可能有限,而昂贵的设备一开始就可能负担不起。3
因此,价格只是可及性的一个方面。如果廉价检测工具经不起运输、无法可靠操作,或出现问题时得不到支持,那就没有解决问题。这项研究的严肃之处,部分在于它认识到了这些限制,而不是把实验室设备变小自动视为能给患者带来突破。
超越荣誉的职业生涯
在2024年接受《哈佛公报》采访时,怀特塞兹以一贯直率的方式表达了他对科学独立性的看法。8
科学家不是照章办事的行当。
他的职业生涯让这种独立性有了务实的方向。理解分子涂层与设计能应对艰苦环境的检测工具并非同一任务,但两者都要求关注事物实际如何运作。怀特塞兹拓展了化学家能够控制的范围。他的诊断研究进一步追问:这种控制能力能为谁服务?这一问题的重要性将超越他的生命。
来源11
Dead-People.com
Google News Ireland (IE:en)
- HeyDay News
按媒体查看所有来源
来自 11 家媒体的 23 个来源· 引用最多的优先
harvard.edu12
- Diagnostics, Bioanalytics, and other Tools for Global Health | Whitesides Research Group
- George Whitesides receives Kavli Prize — Harvard Gazette
- Simple Telemedicine for Developing Regions: Camera Phones and Paper-Based Microfluidic Devices for Real-Time, Off-Site Diagnosis
- Whitesides Research Group
- George Whitesides became giant of chemistry by keeping it simple — Harvard Gazette
- Department of Chemistry and Chemical Biology
- George Whitesides | Department of Chemistry and Chemical Biology
- George M. Whitesides
- People | Whitesides Research Group
- Latest News | Whitesides Research Group
- George M Whitesides | Whitesides Research Group
- Two Harvard Scientists Win National Medal of Science — Harvard Gazette
chemistryviews.org1
Euclidcaltech.edu1
Google News Ireland (IE:en)acs.org1
National Science and Technology Medals Foundationnationalmedals.org1
NSF - U.S. National Science Foundationnsf.gov1
The Analytical Scientisttheanalyticalscientist.com1
wikipedia.org最先1
- 首次报道于
- George M. Whitesides
播出原貌
- George Whitesides has died at 87. He spent more than four decades at Harvard, helping scientists control materials at the molecular scale. His work also reached toward simpler medical tests. How far did he get in making sophisticated chemistry useful beyond well-equipped laboratories?
- Whitesides worked across materials and surface chemistry, organic synthesis and nanotechnology. He studied how chemistry could change the behavior of materials, while also pursuing tools that might make laboratory testing smaller and more affordable. His career combined fundamental research with the practical demands of using science outside a laboratory.
- Whitesides was born in Louisville, Kentucky, on August third, 1939. His full name was George McClelland Whitesides. His exact death date hasn't been settled, although the announcements agree that he was 87.
- A coating just one molecular layer thick became a central part of his scientific legacy. Researchers call these coatings self-assembled monolayers. They allow scientists to engineer a surface's properties by controlling its molecular coating. The achievement was a way to change how a material behaves through its surface.
- Whitesides shared the 2022 Kavli Prize in Nanoscience with David Allara, Ralph Nuzzo and Jacob Sagiv. Together, their recognition honored contributions to developing self-assembled monolayers. The prize reflected a field built through the work of multiple researchers.
- Whitesides also helped connect chemistry with biology. In 2001, he coauthored the review “Soft Lithography in Biology and Biochemistry” with Emanuele Ostuni, Shuichi Takayama, Xingyu Jiang and Donald Ingber. His interests extended into microfluidics, which handles small amounts of liquid, and into paper-based diagnostic devices.
- One team paired paper-based microfluidic devices with camera phones. Their prototype measured biological assay results and exchanged them digitally for off-site analysis. Whitesides worked on it with Andres Martinez, Scott Phillips, Emanuel Carrilho, Samuel Thomas the Third and Hayat Sindi.
- Microfluidic systems can use smaller quantities of samples and reagents. They can also help researchers manipulate biological cells and automate experiments. Smaller instruments could bring costs down. Those are potential advantages of the technology. Making a useful medical tool also means designing for the conditions where someone will actually use it.
- Subscribe to this channel as we follow Whitesides's scientific legacy and efforts to make diagnostic tools more accessible.
- His group identified four obstacles to diagnostics in low-resource settings. Tests must withstand harsh transport and storage. Users may have little training and work under stress. Support and maintenance can be limited. And expensive equipment can put a tool beyond reach.
- A low price addresses only part of that problem. The paper-and-phone work demonstrated a prototype approach to measuring and sharing test results. Turning that approach into dependable care requires tools that people can operate and support under difficult conditions. That practical ambition ran alongside a long career in university laboratories.
- Whitesides earned his Harvard undergraduate degree in 1960. He joined the MIT faculty in 1963 and received his Caltech doctorate in 1964, working with J. D. Roberts. His MIT appointment continued until 1982.
- At Harvard, his appointments included Mallinckrodt Professor of Chemistry and, later, Woodford L. and Ann A. Flowers University Professor. His group biography subsequently listed him as University Research Professor. Across those stages, he spent more than four decades researching, teaching and mentoring.
- Whitesides received the 1998 National Medal of Science in chemistry. President Bill Clinton presented it in the White House East Room in April 1999. The Priestley Medal followed in 2007. Harvard announced his selection for the shared Kavli Prize in June 2022.
- He also co-founded twelve companies. His legacy includes internationally recognized molecular surface engineering and a prototype for linking simple tests with remote analysis. The diagnostic work explored a practical route toward greater access, while confronting the difficulties of making equipment affordable, maintainable and usable.
- Whitesides carried that independence across his research career. In a 2024 interview, he put his view of scientific work bluntly. “The scientist is not in the business of following instructions.”
译文更新于
讨论
此处的帖子属于“George M. Whitesides' death”,会显示在该新闻事件的每篇报道下。





